Not Signed In -
Breast Cancer |
Cancer of breast; Cancer, Breast; Malignant neoplasm of breast; malignant tumor of breast; Mammary cancer; Paget's Disease of Breast |
Paget's disease of the breast, also known as Paget's disease of the nipple, is a condition that outwardly may have the appearance of eczema - with skin changes involving the nipple of the breast. Symptoms Usually only affecting one nipple, there may be redness, oozing and crusting, and a sore that does not heal. Causes Paget's disease is caused by breast cancer and is present in about 2% of all breast cancers. It typically results when malignant cells from an underlying carcinoma that ...
Wikipedia - [full article]
Breast Cancer Clinical Trials
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005798 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer; ...
- Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00002616 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; inflammatory breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004156 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
ClinicalTrials.gov Identifier: NCT00002509 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00004174 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002680 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00046891 - Active, not recruiting
neurotoxicity; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003253 - Active, not recruiting
Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Nutrition Intervention in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002564 - Active, not recruiting
prevention of breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00080626 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00054418 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004172 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
ClinicalTrials.gov Identifier: NCT00024102 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00003068 - Active, not recruiting
stage IIIB breast cancer; Drug Toxicity; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
ClinicalTrials.gov Identifier: NCT00033397 - Recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00004205 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; breast cancer in situ; recurrent breast cancer; ductal breast carcinoma; ...
- Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
ClinicalTrials.gov Identifier: NCT00002707 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Trastuzumab and Radiation Therapy in Treating Women With Stage III or Stage IV Invasive Primary Cancer of the Breast
ClinicalTrials.gov Identifier: NCT00006109 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
- Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00028704 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer
- ICI 182780 in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00002460 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
ClinicalTrials.gov Identifier: NCT00003016 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002581 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075413 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer; stage IIIA breast cancer
- Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
ClinicalTrials.gov Identifier: NCT00070031 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00080665 - Active, not recruiting
Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00066378 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
ClinicalTrials.gov Identifier: NCT00015886 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Physical Activity in Preventing Breast Cancer in Women With a History of Breast Cancer or at High Risk for Breast Cancer Who Are Not Physically Active
ClinicalTrials.gov Identifier: NCT00095849 - Active, not recruiting
Breast Cancer
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002579 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Tamoxifen in Treating Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002542 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00088829 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Erlotinib in Treating Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00024219 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00008034 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006120 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer
- Sorafenib in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00096434 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006032 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Medroxyprogesterone in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
- Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
ClinicalTrials.gov Identifier: NCT00096369 - Active, not recruiting
Breast Cancer; lobular breast carcinoma in situ
- Letrozole With or Without CCI-779 in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00061971 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00093795 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
- Doxorubicin and Paclitaxel in Treating Women Who are Undergoing Surgery For Breast Cancer
ClinicalTrials.gov Identifier: NCT00096291 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00004906 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
ClinicalTrials.gov Identifier: NCT00005822 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer; Male Breast Cancer
- Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00002627 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00072319 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
ClinicalTrials.gov Identifier: NCT00066547 - Active, not recruiting
recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00016406 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004018 - Active, not recruiting
stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
ClinicalTrials.gov Identifier: NCT00059852 - Active, not recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00003953 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003519 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
- High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003392 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer and Positive Axillary Lymph Nodes
ClinicalTrials.gov Identifier: NCT00003782 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
ClinicalTrials.gov Identifier: NCT00238316 - Active, not recruiting
Breast Cancer
- High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00003032 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00004925 - Active, not recruiting
stage IIIB breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00107510 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00002679 - Active, not recruiting
Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer
- Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00026442 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
ClinicalTrials.gov Identifier: NCT00005886 - Active, not recruiting
stage I breast cancer; intraductal breast carcinoma; stage II breast cancer; breast cancer in situ
- Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- PET Scans in Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00109785 - Recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002837 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00005058 - Active, not recruiting
stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002529 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003877 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003638 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00079118 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00028964 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer; Drug Toxicity
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Donor Lymphocyte Infusion in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00006261 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00146562 - Active, not recruiting
Breast Cancer; stage I breast cancer; Stage II breast cancer
- Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
- Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00054301 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; intraductal breast carcinoma; breast cancer in situ
- Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00019643 - Active, not recruiting
Depression; Stage I Breast Cancer; Stage IIIA Breast Cancer; Nutrition; Stage II Breast Cancer; Psychosocial Effects/Treatment; Quality of Life
- GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/neu
ClinicalTrials.gov Identifier: NCT00085020 - Active, not recruiting
stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
- Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00047255 - Active, not recruiting
stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
ClinicalTrials.gov Identifier: NCT00083018 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00002498 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
ClinicalTrials.gov Identifier: NCT00039546 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Preoperative Cisplatin in Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
- Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00003654 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Chemoprevention Therapy Plus Surgery in Treating Patients With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003099 - Active, not recruiting
stage I breast cancer; ductal breast carcinoma; invasive ductal breast carcinoma; prevention of breast cancer; stage II breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003679 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
- Irinotecan and Cetuximab in Treating Patients With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00275041 - Active, not recruiting
Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00074139 - Active, not recruiting
stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00068588 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
ClinicalTrials.gov Identifier: NCT00016432 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00010075 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women with Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00005980 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.
ClinicalTrials.gov Identifier: NCT00188721 - Recruiting
Breast Cancer
- Paclitaxel and Carboplatin in Treating Women Who are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00096343 - Active, not recruiting
invasive ductal breast carcinoma; invasive lobular breast carcinoma; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; ...
Resources
- ''''Improving the Health of the Public: Part I'''' (HealthWorld)
- A New Treatment for Hot Flashes: Antidepressants (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page
